Ashish Kacholia is a prominent Indian stock market investor known for his expertise in identifying high-growth mid-cap and small-cap companies. With a diversified portfolio across sectors like manufacturing, technology, and pharmaceuticals, he has gained recognition for his strategic investments and has built a reputation as a savvy market player. As per the latest corporate shareholdings filed, Ashish Kacholia publicly holds 40 stocks with a net worth of over Rs. 2,473.4 Cr.
List of stocks backed by Ashish Kacholia with high piotroski up to 8:
1. Shaily Engineering Plastics Ltd
Shaily Engineering Plastics Limited is an India-based exporter of plastic components. The Company manufactures high-precision injection molded plastic components. The Company operates through the manufacture and sale of customized components made up of plastic and other materials.
With a market capitalization of Rs 8,092 per share, the shares closed at Rs 1,761 per share, decreased around 1.74 percent as compared to the previous closing price. The company has a high piotroski of ‘Eight’.
Ace investor Ashish Rameshchandra Kacholia holds 2,393,680 equity shares equivalent to 5.2 percent as of December 2024. Analyzing the company’s financial performance, revenue zoomed by 25 percent from Rs 158 crore in Q3FY24 to Rs 198 crore in Q3FY25, during the same time, net profit stretched by 66 percent from Rs 15 crore to Rs 25 crore.
2. Man Industries (India) Ltd
Man Industries (India) Limited is an India-based company, which is engaged in the business of manufacturing, processing, and trading of submerged arc welded pipes and steel products. The Company offers longitudinal submerged arc welded line pipes for use in oil, gas, petrochemicals, fertilizers, and dredging, and helically.
With a market capitalization of Rs 1,736 per share, the shares closed at Rs 268 per share, decreased around 1.31 percent as compared to the previous closing price. The company has a high piotroski of ‘Seven’.
Ace investor Ashish Rameshchandra Kacholia holds 13,62,395 equity shares equivalent to 2.10 percent as of December 2024. Analyzing the company’s financial performance, revenue plummeted by 12 percent from Rs 833 crore in Q3FY24 to Rs 732 crore in Q3FY25, during the same time, net profit stretched by 9 percent from Rs 31 crore to Rs 34 crore.
Also read: Stock skyrockets 16% after receiving 20-year US patent for its Cross Sealing Device
3. Dhabriya Polywood Ltd
Dhabriya Polywood Limited is a manufacturer and supplier of extruded chloride (PVC)/ un-plasticized polyvinyl chloride (uPVC) profile sections and Dstona sheets & moldings for various furnishing and furniture applications, uPVC window and doors, and aluminum window systems.
With a market capitalization of Rs 404 per share, the shares closed at Rs 373 per share, increased around 0.17 percent as compared to the previous closing price. The company has a high piotroski of ‘Eight’.
Ace investor Ashish Rameshchandra Kacholia holds 7,22,345 equity shares equivalent to 6.67 percent as of December 2024. Analyzing the company’s financial performance, revenue zoomed by 4 percent from Rs 52.02 crore in Q3FY24 to Rs 54.90 crore in Q3FY25, during the same time, net profit stretched by 14 percent from Rs 3.33 crore to Rs 3.82 crore.
4. Beta Drugs Ltd
Beta Drugs Limited is an India-based company that is engaged in the business of manufacturing oncology medicines. The Company offers a range of oncology products including tablets, capsules, and injections.
With a market capitalization of Rs 1,721 per share, the shares were trading at Rs 1,790 per share, increasing around 1.95 percent as compared to the previous closing price. The company has a high piotroski of ‘Six’.
Ace investor Ashish Rameshchandra Kacholia holds 1,203,644 equity shares equivalent to 12.5 percent as of December 2024. Analyzing the company’s financial performance, revenue zoomed by 60 percent from Rs 112 crore in Q3FY24 to Rs 180 crore in Q3FY25, during the same time, net profit stretched by 50 percent from Rs 16 crore to Rs 24 crore.
Written by Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.